Patent · US Active

T cells surface-loaded with immunostimulatory fusion molecules and uses thereof

US11471490B2 · kind B2 · utility

6Cited by
28References
30Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 3, 2018
Grant dateOct 18, 2022
Priority date
Expiry dateJul 3, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2501/2315
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Immunostimulatory fusion molecules that include an immune cell targeting moiety and a cytokine molecule, pharmaceutical and formulations thereof, and methods of using and making the same, are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.